27 completed, 9 unknown, 4 recruiting, 3 terminated. 46 Phase 2, 4 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 46 | Completed 27, Unknown 9, Recruiting 4, Terminated 3, Not yet recruiting 2, Active not recruiting 1 |
| Phase 3 | 4 | Completed 3, Not yet recruiting 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Infectious Encephalitis: new trials by email Literature Review of Infectious Encephalitis trials Research Report on Infectious Encephalitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intravenous Brincidofovir as an Antiviral for Treatment of Progressive Multifocal Leukoencephalopathy: A Pilot Study Brincidofovir - Progressive Multifocal Leukoencephalopathy | Phase 2 | Recruiting | National Institute of Neurological Disorders and Stroke (NINDS) | 24 | 2026-06-05 | 2026-07-22 |
| T-cell Therapy in Patients With PML Application of T-lymphocytes - Progressive Multifocal Leucoencephalopathy (PML) | Phase 2 | Recruiting | Hannover Medical School | 23 | 2026-02-06 | 2026-10-15 |
| High-Titer Neutralizing Plasma for West Nile Fever in Hospitalized Patients Plasma - West Nile Fever | Phase 2 | Recruiting | Gili Regev-Yochay MD | 37 | 2025-07-30 | 2025-08-26 |
| A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine MVA-BN-WEV, Placebo - Encephalitis | Phase 2 | Active not recruiting | Bavarian Nordic | 411 | 2025-03-10 | 2025-10-01 |
| A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults GBP560-A, GBP560-B, IXIARO - Japanese Encephalitis Virus Disease | Phase 1 / Phase 2 | Completed | SK Bioscience Co., Ltd. | 161 | 2025-02-24 | 2026-09-11 |
| Early Interferon-beta Treatment for West-Nile Virus Infection Rebif 44 MCG Per 0.5 ML Prefilled Syringe, Saline - West Nile Virus, West Nile Fever Encephalitis | Phase 2 | Unknown | Tel-Aviv Sourasky Medical Center | 100 | 2024-07-14 | 2024-07-23 |
| Pembrolizumab in Progressive Multifocal Leukoencephalopathy (PML) in Immunocompromised Patients Without HIV Infection Pembrolizumab, 25 mg/ml solution for intravenous (IV) injection - Progressive Multifocal Leukoencephalopathy | Phase 2 / Phase 3 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 33 | 2024-04-01 | 2024-02-26 |
| A Phase 2 Study Evaluating JCPyV-specific T Cell Therapy for PML CE-VST01-JC - Progressive Multifocal Leukoencephalopathy | Phase 2 | Unknown | Cellevolve Bio Inc | 60 | 2023-02-01 | 2022-09-16 |
| An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity Stamaril, Imojev, Ixiaro - Infectious Disease, Yellow Fever | Phase 2 | Unknown | Singapore General Hospital | 70 | 2022-09-28 | 2023-04-12 |
| Safety and Immunogenicity Study of Venezuelan Equine Encephalomyelitis (VEE) Vaccine as Booster Vaccine in Adults 0.5 mL Inactivated, Dried, C-84, TSI-GSD 205, Lot 7, Run 1 - Venezuelan Equine Encephalomyelitis | Phase 2 | Not yet recruiting | U.S. Army Medical Research and Development Command | 500 | 2021-06-01 | 2021-02-16 |
| Treatment of PD-1 Inhibitor in AIDS-associated PML Pembrolizumab - Progressive Multifocal Leukoencephalopathy, AIDS | Phase 2 | Unknown | First Affiliated Hospital of Zhejiang University | 10 | 2019-08-20 | 2019-09-20 |
| Safety of Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Children From 9-24 Months of Age JEVAX, JECEVAX - Japanese Encephalitis | Phase 2 | Completed | National Institute of Hygiene and Epidemiology, Vietnam | 220 | 2017-06-02 | 2018-09-17 |
| Safety and Immunogenicity Study of the Western Equine Encephalitis (WEE) Vaccine Western Equine Encephalitis (WEE) Vaccine - Western Equine Encephalitis | Phase 2 | Unknown | U.S. Army Medical Research and Development Command | 500 | 2015-12-15 | 2021-02-11 |
| Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus Allogeneic BK-specific Cytotoxic T-lymphocytes, Laboratory Biomarker Analysis - Acquired Immunodeficiency Syndrome, BK Virus Infection | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 100 | 2015-07-23 | 2026-09-04 |
| Safety and Immunogenicity of JECEVAX in Young Children JEVAX, JECEVAX-1, JECEVAX-0.8 - Japanese Encephalitis | Phase 2 | Completed | National Institute of Hygiene and Epidemiology, Vietnam | 200 | 2015-04-01 | 2016-06-28 |
| New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly FSME-immune - Tick-borne Encephalitis | Phase 2 / Phase 3 | Completed | Sormland County Council, Sweden | 250 | 2015-01-01 | 2021-02-10 |
| Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients TBE virus vaccine - Tick Borne Encephalitis | Phase 2 | Completed | Medical University of Vienna | 34 | 2014-07-01 | 2022-02-03 |
| The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans Japanese Encephalitis vaccine, Yellow Fever vaccine - Yellow Fever, Encephalitis, Japanese | Phase 2 | Completed | Singapore General Hospital | 84 | 2013-10-01 | 2016-04-20 |
| Humoral Response to Tick-borne Encephalitis Vaccine in Elderly FSME-immune - Tick-borne Encephalitis | Phase 2 / Phase 3 | Completed | Sormland County Council, Sweden | 200 | 2011-09-01 | 2015-11-18 |
| Vaccine Study for Tick-Borne Encephalitis Virus (TBEV) FSME-IMMUN 0.5ml Baxter - Tick-Borne Encephalitis, Encephalitis, Tick-Borne | Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 69 | 2009-09-25 | 2018-07-05 |
Showing 20 of 46. Sign in to see all of them.
Encephalitis, Japanese (14) · Encephalitis, Tick-Borne (10) · Leukoencephalopathy, Progressive Multifocal (9) · Encephalitis (6) · West Nile Fever (5) · Acquired Immunodeficiency Syndrome (3) · Encephalomyelitis, Venezuelan Equine (3) · HIV Infections (3) · Yellow Fever (3) · Encephalomyelitis, Eastern Equine (2) · Virus Diseases (2) · AIDS-Related Opportunistic Infections (1) · Alphavirus Infections (1) · Carcinoma, Merkel Cell (1) · Central Nervous System Diseases (1)
Brain Diseases (46) · Central Nervous System Infections (46) · Central Nervous System Viral Diseases (46) · Infections (46) · Neuroinflammatory Diseases (46) · Central Nervous System Diseases (45) · Encephalitis, Viral (45) · Nervous System Diseases (45) · Virus Diseases (44) · RNA Virus Infections (41) · Encephalitis (40) · Arbovirus Infections (36) · Encephalitis, Arbovirus (36) · Vector Borne Diseases (36)
Vaccines (4) · Desiccation (3) · Japanese Encephalitis Vaccines (2) · Saline Solution (2) · pembrolizumab (2) · Cytarabine (1) · Didanosine (1) · Enfuvirtide (1) · FSME-IMMUN vaccine (1) · Filgrastim (1) · Hepatitis A Vaccines (1) · Immune Checkpoint Inhibitors (1) · Immunoglobulins, Intravenous (1) · Injections (1) · Interferon beta-1a (1)
U.S. Army Medical Research and Development Command (6) · Pfizer (5) · Sanofi (5) · Sanofi Pasteur, a Sanofi Company (3) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · National Institute of Hygiene and Epidemiology, Vietnam (2) · Singapore General Hospital (2) · Sormland County Council, Sweden (2) · Assistance Publique - Hôpitaux de Paris (1) · Bavarian Nordic (1) · Biogen (1) · Cellevolve Bio Inc (1) · Elisabethinen Hospital (1) · First Affiliated Hospital of Zhejiang University (1) · French National Agency for Research on AIDS and Viral Hepatitis (1)
United States (16) · Germany (6) · Austria (5) · Australia (4) · Finland (2) · France (2) · India (2) · Israel (2) · Singapore (2) · Sweden (2) · Thailand (2) · Vietnam (2) · Brazil (1) · China (1) · Czechia (1)
Anthony Cardile, DO (2) · Robert Rivard, MD (2) · Thiem D Vu, MD., PhD. (2) · Ulrich Behre, MD (2) · Ajit Rayamajhi, MBBS, MD (1) · Anand Dubey, M.D (1) · Anthony P Cardile, DO, MAJ (1) · Atul Shanker, Dr. (1) · Bakul B. Javadekar, M.D. (1) · Biao Zhu, PhD (1) · Carlos A. Fierro, MD (1) · Christina Forstner, MD (1)
PMID 15714427, PMID 19143532, PMID 20856164, PMID 20864814, PMID 21148499, PMID 21150279, PMID 21738597, PMID 23733308, PMID 25872531, PMID 25886645, PMID 27686833, PMID 27815383, PMID 30304652, PMID 32728481, PMID 33763778, PMID 33899755, PMID 33929874, PMID 34452033, PMID 35101266, PMID 36780676, PMID 36969244, PMID 39794472, PMID 42402341, PMID 5063895
2005 (1), 2023 (1)